Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus

被引:23
|
作者
Papp, Ferenc [1 ,2 ]
Batista, Cesar V. F. [3 ]
Varga, Zoltan [1 ]
Herceg, Monika [1 ]
Roman-Gonzalez, Sergio A. [3 ]
Gaspar, Rezso [1 ]
Possani, Lourival D. [3 ]
Panyi, Gyorgy [1 ,2 ]
机构
[1] Univ Debrecen, Dept Biophys & Cell Biol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Biophys & Cell Biol,Res Ctr Mol Med, H-4012 Debrecen, Hungary
[3] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico
关键词
Kv1.3; Kv1.2; Toxin; Scorpion; GATED POTASSIUM CHANNELS; HUMAN T-LYMPHOCYTES; K+ CHANNEL; PROTEOMIC ANALYSIS; SCORPION TOXINS; BINDING-SITE; ALPHA; INACTIVATION; ION; NOMENCLATURE;
D O I
10.1016/j.toxicon.2009.05.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using high-performance liquid chromatography Tst26, a novel potassium channel blocker peptide, was purified from the venom of the Brazilian scorpion Tityus stigmurus. its primary structure was determined by means of automatic Edman degradation and mass spectrometry analysis. The peptide is composed of 37 amino acid residues and tightly folded through three disulfide bridges, similar to other K+ channel blocking peptides purified from scorpion venoms. It contains the "essential dyad" for K+ channel recognition comprised of a lysine at position 27 and a tyrosine at position 36. Electrophysiological assays revealed that Tst26 blocked hKv1.2 and hKv1.3 channels with high affinity (K-d = 1.9 nM and 10.7 nM, respectively) while it did not affect several other ion channels (mKv1.1, hKv1.4, hKv1.5, hERG, hIKCa1, hBK, hNav1.5) tested at 10 nM concentration. The voltage-dependent steady-state parameters of K+ channel gating were unaffected by the toxin in both channels, but due to the fast association and dissociation kinetics Tst26 slowed the rate of inactivation of Kv1.3 channels. Based on the primary structure, the systematic nomenclature proposed for this peptide is alpha-KTx 4.6. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 50 条
  • [21] PHARMACOLOGICAL CHARACTERIZATION OF 5 CLONED VOLTAGE-GATED K+ CHANNELS, TYPES KV1.1, KV1.2, KV1.3, KV1.5, AND KV3.1, STABLY EXPRESSED IN MAMMALIAN-CELL LINES
    GRISSMER, S
    NGUYEN, AN
    AIYAR, J
    HANSON, DC
    MATHER, RJ
    GUTMAN, GA
    KARMILOWICZ, MJ
    AUPERIN, DD
    CHANDY, KG
    MOLECULAR PHARMACOLOGY, 1994, 45 (06) : 1227 - 1234
  • [22] Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker BK+-channels with distinctly different affinities
    Batista, CVF
    Gómez-Lagunas, F
    de la Vega, RCR
    Hajdu, P
    Panyi, G
    Gáspár, R
    Possani, LD
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2002, 1601 (02): : 123 - 131
  • [23] Explanation of Structure and Function of kv1.3 Potent Blocker From Mesobuthus eupeus Venom Gland: A New Promise in Drug
    Khodayar, Mohammad Javad
    Mahdavinia, Masoud
    Baradaran, Masoumeh
    Jalali, Amir
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2022, 17 (03)
  • [24] Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels
    Koo, GC
    Blake, JT
    Shah, K
    Staruch, MJ
    Dumont, F
    Wunderler, D
    Sanchez, M
    McManus, OB
    Sirotina-Meisher, A
    Fischer, P
    Boltz, RC
    Goetz, MA
    Baker, R
    Bao, JM
    Kayser, F
    Rupprecht, KM
    Parsons, WH
    Tong, XC
    Ita, IE
    Pivnichny, J
    Vincent, S
    Cunningham, P
    Hora, D
    Feeney, W
    Kaczorowski, G
    Springer, MS
    CELLULAR IMMUNOLOGY, 1999, 197 (02) : 99 - 107
  • [25] A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
    Wang, Yuqing
    Zhu, Duolong
    Ortiz-Velez, Laura C.
    Perry, Jacob L.
    Pennington, Michael W.
    Hyser, Joseph M.
    Britton, Robert A.
    Beeton, Christine
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (02)
  • [26] Inhibiting effector memory T cells with SHK(LS), a novel peptide blocker of the KV1.3 potassium channel.
    Uemura, M.
    Becton, C.
    Matheu, M. P.
    Parker, I.
    Pennington, M. W.
    Cahalan, M. D.
    Chandyt, K. G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S120 - S120
  • [27] Extracellular Linkers Completely Transplant the Voltage Dependence from Kv1.2 Ion Channels to Kv2.1
    Elinder, Fredrik
    Madeja, Michael
    Zeberg, Hugo
    Arhem, Peter
    BIOPHYSICAL JOURNAL, 2016, 111 (08) : 1679 - 1691
  • [28] Structural characterization of a novel peptide with antimicrobial activity from the venom gland of the scorpion Tityus stigmurus: Stigmurin
    de Melo, Edinara Targino
    Estrela, Andreia Bergamo
    Gomes Santos, Elizabeth Cristina
    Lima Machado, Paula Renata
    Silva Farias, Kleber Juvenal
    Torres, Taffarel Melo
    Carvalho, Eneas
    Matos Santos Lima, Joao Paulo
    Silva-Junior, Aronbio Antonio
    Barbosa, Euzebio Guimaraes
    Fernandes-Pedrosa, Matheus de Freitas
    PEPTIDES, 2015, 68 : 3 - 10
  • [29] Specific Kv1.3 Blocker Acts as a Novel Therapeutic Strategy in Brain Injury Induced by Irradiation
    Tang, Yamei
    Wang, Yiping
    Lu, Kui
    Pennington, Michael
    Peng, Ying
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2009, 24 (05) : 404 - 404
  • [30] ImKTx88, a novel selective Kv1.3 channel blocker derived from the scorpion Isometrus maculates
    Han, Song
    Hu, Youtian
    Zhang, Ruhong
    Yi, Hong
    Wei, Jingjing
    Wu, Yingliang
    Cao, Zhijian
    Li, Wenxin
    He, Xiaohua
    TOXICON, 2011, 57 (02) : 348 - 355